Corcept Therapeutics Inc header image

Corcept Therapeutics Inc

CORT

Equity

ISIN null / Valor 1812837

NASDAQ (2026-05-01)

USD 51.42+10.5%

Corcept Therapeutics Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Corcept Therapeutics Inc. is a biopharmaceutical company focused on therapies that modulate the glucocorticoid receptor to treat diseases driven by excess cortisol signaling; it commercializes Korlym (mifepristone) in the United States for control of hyperglycemia in patients with endogenous Cushing’s syndrome who are not candidates for surgery and generates revenue from product sales while advancing a pipeline of selective glucocorticoid receptor modulators, most notably relacorilant, which is being evaluated in Cushing’s and in combination regimens for certain solid tumors. The company’s operations combine clinical development, regulatory work and commercial activities to pursue additional indications for its marketed product and to progress investigational GR-targeting candidates, and it is publicly traded on NASDAQ under the ticker CORT.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-28.1%1Y

126%3Y

126%5Y

Performance

89.9%1Y

81.5%3Y

68.8%5Y

Volatility

5470 M

Market cap (USD)

3,274,664

Daily traded volume (Shares)

51.95 / 50.17

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Embla Medical hf

Embla Medical hf Valor: 1060135

Annual Return

-50%0%+50%

Risk level

110

1.71%DKK 26.75

H. Lundbeck A/S

H. Lundbeck A/S Valor: 119252584

Annual Return

-50%0%+50%

Risk level

110

-1.13%DKK 35.00

Teladoc Health Inc

Teladoc Health Inc Valor: 28438140

Annual Return

-50%0%+50%

Risk level

110

6.60%USD 6.46

Bristol-Myers Squibb Co

Bristol-Myers Squibb Co Valor: 914188

Annual Return

-50%0%+50%

Risk level

110

-3.91%USD 58.22

DocMorris Ltd

DocMorris Ltd Valor: 4261528

Annual Return

-50%0%+50%

Risk level

110

-1.11%CHF 7.15

Demant A/S

Demant A/S Valor: 32651962

Annual Return

-50%0%+50%

Risk level

110

3.47%DKK 209.00

Paul Hartmann AG

Paul Hartmann AG Valor: 1547181

Annual Return

-50%0%+50%

Risk level

110

-0.97%EUR 204.00

Ensign Group Inc

Ensign Group Inc Valor: 3109721

Annual Return

-50%0%+50%

Risk level

110

-1.59%USD 183.72

Estee Lauder Companies Inc

Estee Lauder Companies Inc Valor: 99350

Annual Return

-50%0%+50%

Risk level

110

3.38%USD 79.30

Alk-Abello A/S

Alk-Abello A/S Valor: 117689788

Annual Return

-50%0%+50%

Risk level

110

1.51%DKK 242.00

SIX

FactSet

Clearbit

Logos provided by Clearbit